SCHEMBL7465806

SCHEMBL7465806

CN(C)c1cc2c(cc1-c1c(/C=C3/SC(=O)NC3=O)cccc1OC(F)(F)F)C(C)(C)CCC2(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.48
GSK3B P49841 2/20 0.47
NR1H4 Q96RI1 1/20 0.44
PIM1 P11309 5/20 0.44
PIM2 Q9P1W9 5/20 0.44
RXRA P19793 1/20 0.42
HPGD P15428 5/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 2/20 0.41
IGF1R P08069 1/20 0.41
GSK3A P49840 1/20 0.40
MEN1 O00255 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TTR P02766 2/20 0.40
PLA2G1B P04054 2/20 0.40
POLB P06746 2/20 0.40
HTT P42858 2/20 0.40
ATG4B Q9Y4P1 2/20 0.40
KDM4E B2RXH2 1/20 0.40
BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7465810 1.00 SCN9A (0.48) SCN9AGSK3BNR1H4PIM1PIM2
SCHEMBL7469547 0.88 RXRA (0.51) SCN9ANR1H4PIM1PIM2RXRA
SCHEMBL7469552 0.88 RXRA (0.51) SCN9ANR1H4PIM1PIM2RXRA
SCHEMBL7459582 0.88 SCN9A (0.49) SCN9AGSK3BNR1H4PIM1PIM2
SCHEMBL7461818 0.88 PIM1 (0.49) SCN9ANR1H4PIM1PIM2RXRA
SCHEMBL7459574 0.88 SCN9A (0.49) SCN9AGSK3BNR1H4PIM1PIM2
SCHEMBL7461821 0.88 PIM1 (0.49) SCN9ANR1H4PIM1PIM2RXRA
SCHEMBL7468651 0.86 GSK3B (0.59) GSK3BPIM1PIM2RXRAHPGD
SCHEMBL7468657 0.86 GSK3B (0.59) GSK3BPIM1PIM2RXRAHPGD
SCHEMBL14492769 0.83 RXRA (0.55) SCN9AGSK3BPIM1PIM2RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP claimed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO claimed